Co-Diagnostics
CODX
77 hedge funds and large institutions have $63.7M invested in Co-Diagnostics in 2021 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 18 increasing their positions, 32 reducing their positions, and 17 closing their positions.
0.1% less ownership
Funds ownership: 0.92% → 0.82% (-0.1%)
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
1% less funds holding
Funds holding: 78 → 77 (-1)
18% less capital invested
Capital invested by funds: $77.6M → $63.7M (-$13.9M)
22% less call options, than puts
Call options by funds: $5.6M | Put options by funds: $7.19M
44% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$962K |
| 2 |
AC
Aristides Capital
Louisville,
Kentucky
|
+$671K |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$559K |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$477K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$401K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$2.15M |
| 2 |
Millennium Management
New York
|
-$1.72M |
| 3 |
WG
Winton Group
London,
United Kingdom
|
-$1.08M |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$801K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$796K |
CODX Hedge Fund Activity: Q4 2021 in Review
77 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q4 2021, worth a combined $63.7M — down 18% from $77.6M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of CODX and 16 opened new positions — a net loss of 1 holder — while 32 trimmed existing stakes and 18 added.
The largest buyer was Renaissance Technologies, adding an estimated $962K. The largest seller was Marshall Wace, exiting entirely with an estimated $2.15M sold.
- 77 institutional investors held Co-Diagnostics (CODX) as of Q4 2021, down from 78 in Q3 2021.
- Funds reported $63.7M of Co-Diagnostics stock for Q4 2021, down 18% quarter-over-quarter.
- 16 funds opened new Co-Diagnostics positions in Q4 2021 and 17 closed out, a net change of -1 holder.
- The largest Co-Diagnostics buyer in Q4 2021 was Renaissance Technologies, an estimated $962K added.
- The largest Co-Diagnostics seller in Q4 2021 was Marshall Wace, an estimated $2.15M sold.
Based on aggregated 13F filings for Q4 2021.